|
|
 |
|
Viewing report
|
|
|
|
2005 Indian Medical Market Report
Golden Triangle Organisation, The, June 2005
India's pharmaceutical, life sciences and medical equipment markets are in the throes of rapid modernization. Drug discovery is underway among large Indian pharmaceutical firms; themselves ramping up research to levels formerly unseen. Consolidations are occurring among drug companies, hospital groups, medical distributors and retail druggists and new service offerings are springing up such as contract research. Finally, India's adherence to new stricter intellectual property laws is changing generic drug manufacturing and sales.
The 2005 Indian Medical Market Report provides an overview of this emerging healthcare market. The report includes salient narratives on top industry players, sector-specific and general economic statistics and important contact information to augment your firm's research. The 2005 Indian Medical Market Report is your firm's roadmap to one of Asia's key emerging markets and includes information on key therapeutic areas targeted by Indian drug companies as well as important joint venture information. The report also includes information on new pharmaceutical and biotechnology polices and regulatory oversight and a look at the changing face of drug and medical equipment distribution.
Other points of interest included in the report:
- Key therapeutic areas targeted by Indian drug companies and new emphasis on lifestyle drug thereapires
- The changing nature of generic drug development and new market entrants
- Distribution of drugs and medical products and the role of stockists and wholesalers
- New biotechnology and medical equipment policy and regulatory initiatives
- Detailed profiles of India's leading pharmaceutical companies and their strategic focus for 2005 and beyond
- Detailed analysis of India's human, industrial and agriculture biotechnology sectors
- Overview of India's public and private hospitals as well as new private health insurance models
- Joint venture and acquisition activity in the pharmaceutical sector
You should read this report if...
...your firm is looking for low-cost advanced chemical capabilities. Indian firms off contract research services which can hasten time to market and provide cost-savings. Plants are FDA-approved and equipped for research into new chemical entities.
...you are a service provider intent on international expansion. India's hospital and health insurance sector is growing tremendously. Private healthcare insurance is being embraced by urban and rural Indians.
...your investors are looking for lower-cost markets for new drug development, either chemical-based or in the life sciences arena. India's biotechnology sector is valued at nearly $1 billion and is poised for growth. Local research talent is equipped to assist multinational firms in molecular-based drug discovery.
|
|
|
|
